Design, Synthesis and Anticancer Evaluation of Fangchinoline Derivatives
AbstractTwenty fangchinoline derivatives were synthesized from the natural product fangchinoline, and their anticancer activities on human breast cancer MDA-MB-231 cell line, human prostate cancer PC3 cell line, human melanoma WM9 cell line and human leukaemia HEL and K562 cell lines were evaluated. The biological result showed that those derivatives exhibited potent activities on inhibiting cancer cell growth, and the structure-activity relationships were investigated. Among them, compound 4g, which was protected by benzoyl group in 7-phenolic position and nitrified in 14-position, showed impressive inhibition on all 5 cancer cell lines, especially WM9 cell line, with an IC50 value of 1.07 µM. Further mechanistic studies demonstrated that compound 4g may induce cancer cell death by apoptotic means. These research results suggested that compound 4g could be a lead for the further development toward an anticancer agent against human melanoma WM9 in the future. View Full-Text
Share & Cite This Article
Liu, Y.; Xia, B.; Lan, J.; Hu, S.; Huang, L.; Chen, C.; Zeng, X.; Lou, H.; Lin, C.; Pan, W. Design, Synthesis and Anticancer Evaluation of Fangchinoline Derivatives. Molecules 2017, 22, 1923.
Liu Y, Xia B, Lan J, Hu S, Huang L, Chen C, Zeng X, Lou H, Lin C, Pan W. Design, Synthesis and Anticancer Evaluation of Fangchinoline Derivatives. Molecules. 2017; 22(11):1923.Chicago/Turabian Style
Liu, Yazhou; Xia, Bin; Lan, Junjie; Hu, Shengcao; Huang, Lan; Chen, Chao; Zeng, Xueyi; Lou, Huayong; Lin, Changhu; Pan, Weidong. 2017. "Design, Synthesis and Anticancer Evaluation of Fangchinoline Derivatives." Molecules 22, no. 11: 1923.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.